Why Is Viking Therapeutics ( $VKTX ) Stock Down -11.19% Today? (Find out why any stock moved today on Tickeron.) Shares of Viking Therapeutics (VKTX) fell 11.19% in Thursday's session, sliding $4.66 from a prior close of $41.65 to $36.99. The decline was driven by an upsized, dilutive $500 million financing, not by any new clinical data. The company priced 7.86 million common shares at $35.00 each — a roughly 16% discount — alongside $225 million of 2.00% convertible senior notes due 2032. The raise came just two days after a 36% surge on promising Phase 2 maintenance data for its obesity candidate VK2735. $EDIT $KURA $IMTX $NAMS $FDMT
published
Why Is Viking Therapeutics ( $VKTX ) Stock Down -11.19% Today? (Find out why any stock moved today on Tickeron.) Shares of Viking Therapeutics (VKTX) fell 11.19% in Thursday's session, sliding $4.66 from a prior close of $41.65 to $36.99. The decline was drive
$VKTX$EDIT$KURA$IMTX$NAMS$FDMT
Latest documented BWB result
$NBIS market result
Exit $NBIS with $3.25 profit per contract
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.